1. Estimate your risk
Where do you live?
Do you have access to urine albumin-to-creatinine ratio and hemoglobin A1c values?
What country do you live in?
How old are you?
 
Note: The risk prediction model used for New Zealand is not validated in those >75 years old.
What is your sex?
What is your ethnicity?
Do you identify as Black?
What is your deprivation quintile?
Do you have a family history of heart disease or stroke?
Do you currently smoke?
Do you currently smoke?
Do you have diabetes?
Click here for a decision aid that estimates additional diabetes-related outcomes.
Note: The risk prediction model used for Europe in patients <70 years old is not validated in those with diabetes.
Do you have atrial fibrillation?
What is your systolic blood pressure?
 
Do you take medications for blood pressure?
Do you take acetylsalicylic acid ("Baby Aspirin") or blood thinners (like warfarin)?
Do you take cholesterol medications?
Are you currently taking a statin?
What is your total cholesterol?
What is your HDL cholesterol?
Note: This decision aid cannot be used to predict cardiovascular risk in people with LDL-cholesterol of 6 mmol/L or greater (>232 mg/dL), as it will substantially under-estimate the risk of cardiovascular events in these people.
Note: A non-HDL-cholesterol concentration above 6.5 mmol/L (≥251 mg/dL) may indicate familial hypercholesterolemia (inherited form of high cholesterol from birth). This decision aid substantially under-estimates the risk of cardiovascular events in patients with familial hypercholesterolemia. As a safety measure, a concentration this high disables the tool.
What is your serum creatinine?
eGFR (2021 CKD-EPI equation)
122 ml/min/1.73m²
What is your social deprivation index?
What is your albumin-to-creatinine ratio?
What is your hemoglobin A1c?
 
Wondering why family history is not included?
Please s
ee the FAQ

10-year risk of cardiovascular disease 
(heart attack, stroke, or death from cardiovascular disease)

5-year risk of cardiovascular disease 
(heart attack, angina, heart failure, stroke/transient ischemic attack, or peripheral vascular disease)

10-year risk of cardiovascular disease 
(coronary heart disease, myocardial infarction, death from coronary heart disease, stroke, and heart failure)

10-year risk of cardiovascular disease 
(heart attack, angina, heart failure, stroke, or intermittent claudication)

10-year risk of cardiovascular disease 
(heart attack, stroke, or death from coronary heart disease)

Your risk 8.1%    With treatment 8.1%

 

8.1%
No Event Treatment Benefit Event

Ezetimibe has minimal evidence in primary prevention 

(risk reduction from secondary prevention trial used)

PCSK9 inhibitors have minimal evidence in primary prevention 

(risk reduction from secondary prevention trial used)

Fibrates do not further reduce cardiovascular risk in patients taking a statin

2. Choose your treatments

Lifestyle options

Medication options (only select one)

These options have clear and direct evidence for primary prevention

Non-statin options not recommended for primary prevention in our guideline

No treatment selected
1-